419 related articles for article (PubMed ID: 33722248)
1. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
[TBL] [Abstract][Full Text] [Related]
2. Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p.
He H; Ding M; Li T; Zhao W; Zhang L; Yin P; Zhang W
Lab Invest; 2022 Aug; 102(8):826-837. PubMed ID: 35332261
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
6. BMSC-EV-derived lncRNA NORAD Facilitates Migration, Invasion, and Angiogenesis in Osteosarcoma Cells by Regulating CREBBP
Feng D; Li Z; Yang L; Liang H; He H; Liu L; Zhang W
Oxid Med Cell Longev; 2022; 2022():8825784. PubMed ID: 35281474
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
[TBL] [Abstract][Full Text] [Related]
8. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p.
Chen F; Liu L; Wang S
Cancer Cell Int; 2020; 20():323. PubMed ID: 32694945
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25.
Hu CH; Yang XJ; Yu L; Wang LY; Zhao XC; Han CH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9290-9302. PubMed ID: 33015770
[TBL] [Abstract][Full Text] [Related]
11. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axis.
Mo C; Huang B; Zhuang J; Jiang S; Guo S; Mao X
Clin Transl Med; 2021 Aug; 11(8):e493. PubMed ID: 34459124
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Shi P; Zhang J; Li X; Li W; Li H; Fu P
Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
16. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
[TBL] [Abstract][Full Text] [Related]
17. m
Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA NORAD regulates cancer cell proliferation and migration in human osteosarcoma by endogenously competing with miR-199a-3p.
Wang X; Zou J; Chen H; Zhang P; Lu Z; You Z; Sun J
IUBMB Life; 2019 Oct; 71(10):1482-1491. PubMed ID: 31169973
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NORAD stimulates proliferation and migration of renal cancer via activating the miR-144-3p/MYCN axis.
Zhao W; Wang L; Xu F
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10426-10432. PubMed ID: 33155199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
